![Samarth Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samarth Kulkarni
Directeur Général chez
CRISPR THERAPEUTICS AG
Fortune : 14 M $ au 30/06/2026
Profil
Samarth Kulkarni est président de Casebia Therapeutics LLP. Le Dr Kulkarni siège également au conseil d'administration de Black Diamond Therapeutics, Inc, Repare Therapeutics, Inc et Centessa Pharmaceuticals Ltd. et est directeur général et administrateur de CRISPR Therapeutics AG et directeur de la section des sociétés émergentes de la Biotechnology Innovation Organization. Dans le passé, Samarth Kulkarni a occupé le poste d'associé chez McKinsey & Co, Inc. Il a obtenu un doctorat de l'université de Washington et un diplôme de premier cycle de l'Indian Institute of Technology New Delhi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG 0,26 % | 31/03/2026 | 255 501 ( 0,26 % ) | 14 M $ | 30/06/2026 |
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 26/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Samarth Kulkarni
| Sociétés | Poste | Début |
|---|---|---|
| CRISPR THERAPEUTICS AG | Directeur Général | 01/12/2017 |
| BLACK DIAMOND THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2019 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Directeur Général | - |
Anciens postes connus de Samarth Kulkarni
| Sociétés | Poste | Fin |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 24/06/2026 |
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 26/01/2026 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/07/2015 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Casebia Therapeutics LLP
 Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services | Président | - |
Formation de Samarth Kulkarni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Provides physical, chemical and analytical testing services | Commercial Services |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
